imeglimin: Clinical Trials

5 trials of imeglimin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 15Completed 5

Follow imeglimin: new trials by email Literature Review of imeglimin trials Research Report on imeglimin

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacokinetics of Imeglimin in Hepatic Impaired Subjects
Imeglimin - Hepatic Impairment
Phase 1CompletedPoxel SA142018-11-062020-08-11
Bioequivalence of Imeglimin Tablet Formulations
Imeglimin Reference product, Imeglimin - Bioequivalence
Phase 1CompletedPoxel SA162018-09-032019-01-11
Effect of Cimetidine on the PK of Imeglimin
Imeglimin, Cimetidine - Healthy
Phase 1CompletedPoxel SA162018-06-192018-08-27
Effect of Imeglimin on QT/QTc Intervals in Healthy Subjects
Placebo, Imeglimin, Moxifloxacin - Qt Interval, Variation in
Phase 1CompletedPoxel SA552016-09-012017-02-10
Safety, Tolerability and PK of Imeglimin in Japanese Volunteers
Imeglimin, Placebo - Type 2 Diabetes Mellitus
Phase 1CompletedPoxel SA482015-02-012017-02-10

Conditions studied

Diabetes Mellitus, Type 2 (1)

Sponsors

Poxel SA (5)

Countries

United Kingdom (4)  ·  Germany (1)

Top investigators

Julie Dubourg, MD (1)  ·  Pascale Fouqueray, MD, PhD (1)

Results publications

PMID 32556539

NIH funding

2016 (1)